Effects of Different Doses of Naoxintong Combined With Dual Antiplatelet Therapy in Patients With Cytochrome P450 2c19*2 Gene Mutation After Percutaneous Coronary Intervention

Heart - United Kingdom
doi 10.1136/heartjnl-2012-302920a.257
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Effects of Cytochrome P450 2C19 and Paraoxonase 1 Polymorphisms on Antiplatelet Response to Clopidogrel Therapy in Patients With Coronary Artery Disease

PLoS ONE
Multidisciplinary
2014English

Duration of Dual Antiplatelet Therapy in Patients Treated With Percutaneous Coronary Intervention for Coronary Chronic Total Occlusion

PLoS ONE
Multidisciplinary
2017English

Outcomes of Percutaneous Coronary Intervention Performed With or Without Preprocedural Dual Antiplatelet Therapy

Circulation Journal
MedicineCardiovascular MedicineCardiology
2015English

The Use of Dual Antiplatelet Therapy in Acute Coronary Syndrome and Percutaneous Coronary Intervention

Rational Pharmacotherapy in Cardiology
Cardiovascular MedicinePharmacologyCardiology
2019English

Early and Sustained Dual Oral Antiplatelet Therapy Following Percutaneous Coronary Intervention

JAMA - Journal of the American Medical Association
Medicine
2002English

Triple Versus Dual Antiplatelet Therapy for Coronary Heart Disease Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2013English

Benefits and Harms of Extending the Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention With Drug-Eluting Stents: A Meta-Analysis

The Scientific World Journal
BiochemistryMedicineGeneticsMolecular BiologyEnvironmental Science
2014English

Factors Associated With Platelet Reactivity During Dual Antiplatelet Therapy in Patients With Diabetes After Acute Coronary Syndrome

Scientific Reports
Multidisciplinary
2020English

Clinical Utility of CYP2C19 Genotyping to Guide Antiplatelet Therapy in Patients With an Acute Coronary Syndrome or Undergoing Percutaneous Coronary Intervention

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy